Enhanced S-Cone Syndrome: Clinical Trials

3 trials for Enhanced S-Cone Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 recruiting, 1 terminated. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Active not recruiting 1, Terminated 1
Phase 22Active not recruiting 1, Terminated 1

Follow Enhanced S-Cone Syndrome: new trials by email Literature Review of Enhanced S-Cone Syndrome trials Research Report on Enhanced S-Cone Syndrome

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Assess the Safety and Efficacy of OCU400 for Retinitis Pigmentosa and Leber Congenital Amaurosis
OCU400 Low Dose, OCU400 Med Dose, OCU400 High Dose - Retinitis Pigmentosa, Leber Congenital Amaurosis
Phase 1 / Phase 2Active not recruitingOcugen222022-01-242026-07-31
Interferon Gamma-1b Administered Topically for Macular Edema/Intraretinal Schisis Cysts in Rod-Cone Dystrophy (RCD) and Enhanced S-Cone Syndrome (ESCS)
Interferon gamma-1b - Inherited Ophthalmic Diseases, Inherited Retinal Degeneration
Phase 1 / Phase 2TerminatedNational Eye Institute (NEI)42015-01-142019-08-13
Inherited Retinal Degenerative Disease Registry
Eye Diseases Hereditary, Retinal Disease
RecruitingFoundation Fighting Blindness200002014-06-012026-05-19

Narrower conditions

Cone-Rod Dystrophies (2)  ·  Leber Congenital Amaurosis (2)  ·  Retinitis Pigmentosa (2)  ·  Abetalipoproteinemia (1)  ·  Achromatopsia 3 (1)  ·  Bardet-Biedl Syndrome (1)  ·  Charcot-Marie-Tooth Disease (1)  ·  Choroideremia (1)  ·  Color Vision Defects (1)  ·  Cone Dystrophy (1)  ·  Eye Diseases, Hereditary (1)  ·  Fundus Albipunctatus (1)  ·  Gyrate Atrophy (1)  ·  Kearns-Sayre Syndrome (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Eye Diseases (3)  ·  Genetic Diseases, Inborn (3)  ·  Retinal Degeneration (3)  ·  Retinal Dystrophies (3)  ·  Eye Diseases, Hereditary (2)  ·  Macular Degeneration (2)  ·  Retinal Diseases (2)  ·  Abnormalities, Multiple (1)  ·  Blindness (1)  ·  Brain Diseases (1)  ·  Brain Diseases, Metabolic (1)  ·  Brain Diseases, Metabolic, Inborn (1)  ·  Cardiomyopathies (1)  ·  Cardiovascular Diseases (1)

Interventions

interferon gamma-1b (1)

Sponsors

Foundation Fighting Blindness (1)  ·  National Eye Institute (NEI) (1)  ·  Ocugen (1)

Countries

United States (3)

Top investigators

Jennifer Henrick, RN, MS (1)  ·  Mohamed Genead, MD (1)  ·  Todd Durham, PhD (1)  ·  Wadih Zein, M.D. (1)